Loading...

Home
ETF
CERS

CERS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CERS News

TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%

Jan 14 2026Benzinga

China SXT Pharmaceuticals (SXTC) Closes $10 Million Offering, Stock Rises 17.4%

Jan 14 2026NASDAQ.COM

Cerus (CERS) Q4 Product Revenue Expected at $57.8M, 14% YoY Growth

Jan 12 2026seekingalpha

Cerus Reports 14% Increase in 2025 Product Revenue to $206.1 Million

Jan 11 2026Businesswire

Biotech Stocks Rise in After-Hours Trading Driven by Data Expectations and Momentum Buying

Dec 11 2025NASDAQ.COM

Cerus Corporation Unveils Abstracts and Hosts Industry Workshop on IFC at the 2025 AABB Annual Meeting

Oct 21 2025Newsfilter

Daily Upgrade Report for Validea's James P. O'Shaughnessy Strategy - September 20, 2025

Sep 21 2025NASDAQ.COM

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Jul 21 2025Newsfilter

Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 7/3/2025

Jul 03 2025NASDAQ.COM

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Jul 02 2025Newsfilter

Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 13 2025Newsfilter

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 29 2025Newsfilter

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

May 28 2025Newsfilter

When Should You Buy Cerus Corporation (NASDAQ:CERS)?

May 24 2025Yahoo Finance

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Apr 17 2025Newsfilter

Insider Sale: Chief Legal Officer of $CERS Sells 27,457 Shares

Mar 11 2025NASDAQ.COM